Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

VevaRX vs Found

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
VevaRX logo

VevaRX

7.2
★★★3.6/5

Best for: patients comfortable prepaying by the quarter for a flat per-dose price

Visit VevaRX
VS
Found logo

Found

8.3
★★★★4.2/5

Best for: mainstream telehealth GLP-1 access

Visit Found

VevaRX and Found are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, VevaRX starts lower at $122/mo versus $169/mo, and Found edges ahead overall (8.3 vs 7.2 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

VevaRX

3-month plan — one charge of $367, renews quarterlyCompounded
$122/mo
semaglutide

Site states "Same price at every dose" for this program.

3-month plan — one charge of $467, renews quarterlyCompounded
$156/mo
tirzepatide

The site advertises "$149 per month" for this plan, but $467 over three months is $155.67.

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on 12-month prepaid plan, medication+membership+coaching included; promo_price 99 = $99/mo WITH insurance (12-mo prepaid). Month-to-month: $199/mo insurance, $289/mo cash. Site-wide '$100 off today' checkout promo running.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same single Compounded GLP-1 Plan price as semaglutide — no per-drug split published (final drug/price assignment is quiz-gated); $169/mo cash 12-mo prepaid ($289/mo month-to-month cash), $99/mo insurance prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

'Starting cash price ~$149/mo' on /medication/foundayo comparison table; NEW offering since last verification.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Homepage carousel 'Ozempic® $1100/mo' — unchanged from prior verification.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 490+ providers' prices on their own sites and email you when tracked prices move.

What’s included

VevaRX

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Included

Lab work

Not disclosed

Coaching

Not disclosed

Found

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Included

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

VevaRX

7.2/10

Overall

Found

8.3/10

Value25%

8.0A
vs
B
8.5

Effectiveness25%

7.5A
vs
B
9.0

User Experience15%

6.5A
vs
B
8.0

Trust & Safety15%

6.0A
vs
B
7.3

Accessibility10%

7.0A
vs
B
8.5

Support10%

7.0A
vs
B
7.5

Features & Coverage

FeatureVevaRXFound
Starting Price$122/mo$169/mo
Features6 features3 features
States Available3650
Compounded✓ Yes✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About VevaRX

VevaRX sells compounded semaglutide and tirzepatide as prepaid three-month programs rather than monthly subscriptions, bundling medication, supplies, provider visits and free shipping into one charge. Semaglutide is $367 per quarter and tirzepatide $467, each auto-renewing every three months with a three-month minimum. It publishes an explicit 36-state service list.

Read our full VevaRX review →

About Found

Personalized weight care platform with a self-pay membership model plus medication costs.

Read our full Found review →

Pros & Cons

VevaRX

What we like

  • The service area is published as an explicit 36-state list rather than a blanket "all 50 states" claim.
  • Price is locked before intake — the site states the quoted figure is "locked in price before patient intake".
  • The quarterly charge is stated to include medication, all supplies, provider visits and free 2-3 day shipping.
  • Semaglutide is priced the same at every dose, so titration does not raise the bill.
  • Effective cost is competitive: $367 a quarter for semaglutide works out at about $122 a month.
  • The program includes unlimited physician access and 24/7 care-team support per the FAQ.

Watch-outs

  • There is no month-to-month option — a three-month minimum applies and the plan auto-renews every three months.
  • The tirzepatide plan is advertised at "$149 per month" but $467 across three months is $155.67 a month.
  • The terms and conditions repeatedly reference a different brand, stating "All transactions on trimrx.com are conducted in United States Dollars".
  • The terms list prices ($199 and $349 first-month, $299 and $399) that match none of the prices on the product pages.
  • Other product pages contradict themselves — the sermorelin page shows "$399 total" beside plan text reading "priced at $367".
  • The stated governing law is circular: "the laws of the United States and the state in which VevaRx operates", and the sentence is duplicated.
  • Refunds are granted only in two narrow circumstances, and the compounding pharmacy is not named.

Found

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Watch-outs

  • Limited public information on program details

Our Verdict

Winner: Found

Found edges out VevaRX with a higher overall score of 8.3/10 and is particularly strong for mainstream telehealth GLP-1 access. VevaRX remains a solid alternative, especially if you're looking for patients comfortable prepaying by the quarter for a flat per-dose price.

Choose VevaRX if…

You want patients comfortable prepaying by the quarter for a flat per-dose price and a starting price around $122/mo.

Choose Found if…

You want mainstream telehealth GLP-1 access and a starting price around $169/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

6.9

TMates

Nationwide compounded GLP-1 availability including Puerto Rico

7.9

Trimi Health

Budget-conscious shoppers

8.0

ShedRx

Mainstream telehealth GLP-1 access

VevaRX vs Found: FAQ

VevaRX is cheaper. Its lowest ongoing monthly cash price is $122/mo, compared with $169/mo for Found. We compare standing (not first-month promo) prices so the figures reflect what you'd actually pay month to month.
Found scores higher overall at 8.3/10 versus 7.2/10, and is particularly strong for mainstream telehealth GLP-1 access. That said, VevaRX is a better fit if you want patients comfortable prepaying by the quarter for a flat per-dose price.
Found covers more — 50 states versus 36.
Found is an affiliate partner (we may earn a commission on sign-ups through our links); VevaRX is not. Either way, we rank providers editorially with the same scoring framework and disclose every partnership — being a partner does not buy a higher score.
For Semaglutide, Found is cheaper at $99/mo versus $122/mo at VevaRX.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring VevaRX and Found head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.